Evidence map›Paper›PMID 32737817›Full record

ArticleAIDS and behavior2021

Impact of COVID-19 Pandemic on Sexual Minority Populations in Brazil: An Analysis of Social/Racial Disparities in Maintaining Social Distancing and a Description of Sexual Behavior.

Thiago S Torres, Brenda Hoagland, Daniel R B Bezerra, Alex Garner, Emilia M Jalil, Lara E Coelho, Marcos Benedetti, Cristina Pimenta, Beatriz Grinsztejn, Valdilea G Veloso

Abstract read
In one paragraph

Article in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thiago S TorresFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil. thiago.torres@ini.fiocruz.br.ORCID http://orcid.org/0000-0002-2557-601X
Brenda HoaglandFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil.
Daniel R B BezerraFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil.
Alex GarnerHornet INC, Los Angeles, CA, USA.
Emilia M JalilFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil.
Lara E CoelhoFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil.
Marcos BenedettiFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil.
Cristina PimentaBrazilian Ministry of Health, Brasilia, DF, Brazil.
Beatriz GrinsztejnFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil.
Valdilea G VelosoFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, STD/AIDS Clinical Research Lab, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil.

Funding

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)U01AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI GRINSZTEJN, BEATRIZ · 2008 to 2011
$14.0M
Development of a selective PI3K-Akt-activating neurotrophic small molecule drug, MT-002, for the healing of corneal wounds in Neurotrophic Keratitis.R43EY032018 · NEI · CALISTA THERAPEUTICS, INC. · PI MALLON, ANDREW PETER, MOHAN, RAJIV RAVINDRA · 2021 to 2021
$248k
Conselho Nacional de Desenvolvimento Científico e Tecnológico CNPq, #28/2018Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro Programa Cientista do Nosso Estado; Edital N.º 03/2018NIAID NIH HHS U01 AI069476NIAID NIH HHS UM1 AI069476
6 · The paper itself

Abstract

We conducted a web-based survey to understand the impact of social distancing measures on Brazilian MSM and transgender/non-binary lives. A total of 3486 respondents were included in this analysis and the great majority were cismen (98%). The median age was 32 years (IQR: 27-40), 44% non-white, 36% low schooling and 38% low income. Most of participants reported HIV negative/unknown status (77%). Participants on-PrEP reported more condomless anal sex than those off-PrEP. Conversely, 24% off-PrEP were at substantial HIV-risk. PrEP/ART continuation were reported by the majority, despite reports of impediments to medication refill. Transgender/non-binary reported more mental health problems and challenges to access health care. Social and racial disparities were associated with unattainability of maintaining social distancing. Tailored social and economic support policies during COVID-19 pandemic should be made available to these populations. Challenges for PrEP/ART access will demand the implementation of innovative solutions to avoid the expansion of the HIV epidemic.

Indexed as

Physical DistancingSARS-CoV-2AdultAnti-HIV AgentsBrazilCOVID-19FemaleHIV InfectionsHomosexuality, MaleHumansMalePandemicsPre-Exposure ProphylaxisSexual and Gender MinoritiesSexual BehaviorTransgender PersonsAnti-HIV AgentsBrazilCovid-19MSMPrEPTransgender people

Identifiers

PMID32737817
PMCPMC7394046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.